LivaNova - Health innovation that matters

The material provided is for information purposes only and may contain information about therapies and products that may not be approved in your country. For further information on product availability, please contact your local representative. Prior to use, please consult your specific product labeling for operating instructions and prescriptive information, including indications, contraindications, warnings, precautions, risks and adverse events.
Always refer to the Instructions For Use provided with the product for complete and updated information.
The material provided in this web site is exclusively aimed at healthcare professionals
Not applicable for use in France.


I’M A HEALTHCARE PROFESSIONAL

I’M NOT A HEALTHCARE PROFESSIONAL

newsletter

Subscribe to the newsletter

Product highlights

Protek cannulae portfolio: flexible enough to cover the demands of the most comprehensive Mechanical Circulatory Support programs

The ProtekDuo® line includes our patented dual lumen cannula for right atrium to pulmonary artery bypass and the ProtekSolo® line features two single lumen cannulae set to enable left atrium to femoral artery bypass.

The Protek cannulae line by TandemLife provide unmatched versatility, with a family of unique cannulae designed to meet the needs of the most demanding mechanical cardiac support (MCS) programs.

The ProtekDuo® line includes our patented dual lumen cannula for right atrium to pulmonary artery bypass.

ProtekDuo® is inserted percutaneously at the right internal jugular vein and it is uniquely positioned to drain deoxygenated blood from the right atrium and return it via the pulmonary artery.  ProtekDuo® provides supplemental circulatory support and allows:

  • Less invasive approach with insertion at the RIJ vein for clean access and patient mobility2,3
  • Patient awake and participating in care
  • Enhanced cardiac function, unloading the right ventricle with low incidence of hemolysis4,5

The ProtekSolo® line features two single lumen cannulae set to enable left atrium to femoral artery bypass.  The ProtekSolo® Transseptal cannula is inserted at the femoral vein and placed in the left atrium via a transseptal procedure. The oxygenated blood is then returned via the femoral artery with ProtekSolo® Arterial

ProtekSolo® Transseptal provides left atrial cannulation and allows:

  • Left Ventricle unloading up to 80% with consistent flow rates up to 5L/m6
  • Cardiac Power output of ~1 Watt7
  • The power to recover, resting the left ventricle with left atrial-femoral artery cannulation.6

ProtekSolo® Arterial  includes features unique to the TandemLife family designed to augment patient safety. The cannula provides arterial cannulation ad allows:

  • Secure attachment to patient with suture wings
  • Prevention of over-insertion with rubber stop
  • Simple insertion with friction fit introducer with luer port

 
For more information about LivaNova MCS cannulae, please visit our product highlights section.
 

  1. Schmack et al. – Med Sci Monit Basic Res. 2016 May 5;22:53-7
  2. Aggarwal et al – Catheter Cardiovasc Interv. 2016 Sep;88(3):390-6
  3. Bermudez et al. – Poster presented at ASAIO 2018 (Washington – USA)
  4. O’Neil at al. – Abstract presented at SCAI 2018 (San Diego, USA)
  5. Weil BR et al – JACC Cardiovasc Interv. 2016 Nov 28;9(22):2292-230
  6. Burkhoff D et al – Catheter Cardiovasc Interv. 2012 Nov 1;80(5):816-29
IM-02402